Find Academic Supervisors

Dr. Jacques Archambault is a Professor in the Department of Microbiology and Immunology at McGill University , and an associate member of the Division of Experimental Medicine since 2016. His research focuses on the molecular biology and pathogenesis of human papillomaviruses (HPVs) and polyomaviruses (HPyVs), with an emphasis on their replication mechanisms as episomes in host cells. The Archambault laboratory employs functional genomics, proteomics, and chemical biology approaches to identify cellular pathways exploited by these viruses and develop high-throughput assays for screening small molecule inhibitors of viral replication. Analysis of his recent publications reveals a strong focus on HPV and HPyV replication machinery, including studies on the E1 helicase, UAF1-USP1 interactions, and structural characterization of viral proteins involved in DNA replication. His work bridges virology, oncology, and drug discovery, particularly targeting oncogenic HPV types implicated in anogenital and oropharyngeal cancers, as well as HPyVs like BKPyV and JCPyV that cause pathologies in immunosuppressed patients. Current efforts in the lab aim to elucidate the molecular mechanisms by which HPVs and HPyVs replicate their genomes and to develop antiviral therapies targeting these processes. Techniques such as fluorescence anisotropy, NMR spectroscopy, and crystallography are frequently employed to study protein-DNA and protein-protein interactions critical to viral replication.

• Human Papillomavirus (HPV)
• Polyomavirus
• Viral DNA Replication
• +4 more

Hong Han is an Assistant Professor in the Department of Biochemistry & Biomedical Sciences within McMaster University's Faculty of Health Sciences and a member of the Centre for Discovery in Cancer Research (CDCR). She holds a Canada Research Chair and leads the Han Lab, which focuses on cancer biology, RNA regulation, and innovative high-throughput technologies for therapeutic discovery. Dr. Han earned her Ph.D. from the University of Toronto (2010-2016) and has established herself as a leading researcher in glioblastoma and alternative splicing regulation. Her interdisciplinary research integrates cancer biology, RNA science, and multilayer gene regulation to uncover mechanisms underlying cancer progression and treatment resistance. Her laboratory pioneers integrated technological platforms for large-scale genetic/drug screening and ultra-high-throughput single-cell profiling. The research focuses on three main areas: alternative splicing regulation in cancer (particularly glioblastoma and prostate cancer), multilayer mechanisms of glioblastoma heterogeneity and microenvironment evolution, and multiplexed screening approaches for therapeutic discovery in treatment-resistant cancers. Analysis of Dr. Han's recent publications reveals a strong emphasis on single-cell technologies to characterize glioblastoma heterogeneity, minimal residual disease states, and tumor-immune interactions. Her work increasingly bridges basic RNA biology with translational applications, particularly in developing novel therapeutic strategies targeting splicing networks and immune evasion mechanisms. Canada Research Chair Dr. Han teaches Advanced Techniques in the Biomedical Sciences (BIOCHEM 734). Her research program is supported by multiple funding sources, as evidenced by her extensive publication record in high-impact journals including Nature, Cell, Molecular Cell, and Nature Communications. She employs a comprehensive approach combining in vitro, in vivo, and patient cohort studies with cutting-edge genomic technologies. The Han Lab has developed innovative multiplexed screening platforms that enable simultaneous interrogation of thousands of conditions, ranging from CAR-T cells to small molecule therapeutics. This approach accelerates the discovery of novel cancer targets and therapeutic strategies for treatment-resistant cancers.

• Cancer Biology
• Gene Regulation
• RNA Splicing
• +5 more

Lena Simine is an Associate Professor in the Department of Chemistry at McGill University, affiliated with the Faculty of Science. She holds a B.Sc. (2009) and Ph.D. (2015) from the University of Toronto, followed by a postdoctoral fellowship at Rice University (2015–2019). Her laboratory is located in P&P 118A, focusing on developing computational approaches for modeling molecular phenomena in theoretical chemistry and chemical physics. Her research interests center on computational materials design, quantum dynamics, and the application of machine learning to chemistry. Specific areas include simulating amorphous materials, aptamer design, and quantum systems modeling. She teaches CHEM 365 (Statistical Thermodynamics) and CHEM 593 (Statistical Mechanics and Machine Learning for Chemistry). Her work explores interdisciplinary frontiers, such as path-integral simulations, GFlowNets for molecular design, and the physical principles underlying deep learning in materials science. Recent studies highlight innovations like DeltaGzip for binding affinity prediction and the MAP protocol for 3D disordered matter simulations. Her lab’s contributions span computational methods, material innovation, and quantum phenomena, with a focus on advancing both theoretical frameworks and practical applications in chemistry and materials science.

• Theoretical Chemistry
• Chemical Physics
• Computational Materials Science
• +3 more

Dr. Philippe Campeau is an Associate Clinical Professor in the Department of Pediatrics at the Faculty of Medicine, Université de Montréal. He is affiliated with CHU Sainte-Justine, a major pediatric hospital in Montreal, Quebec, where he works in the Medical Genetics Service. His clinical and research work focuses on genetic disorders affecting children, particularly in the areas of skeletal development and neurogenetics. Dr. Campeau obtained his Doctorate in Medicine from Laval University in Quebec (1998-2003) followed by specialty training in medical genetics at McGill University (2003-2008). He completed postdoctoral training at Baylor College of Medicine (2008-2013), which further developed his expertise in genetic research methodologies. His primary research interests include bone dysplasias , skeletal dysplasias , epilepsy , and epigenetic diseases . Dr. Campeau's laboratory identifies disease-causing genes, deciphers disease pathophysiology, and works to improve the management of children affected by these conditions. His work encompasses exome analysis , functional studies with cell lines and mouse models , and investigations into urea cycle abnormalities . He has made significant contributions to understanding genetic causes of conditions such as Genitopatellar syndrome (KAT6B), osteopetrosis, dysosteosclerosis (SLC29A3), osteogenesis imperfecta, early-onset osteoporosis (WNT1), Yunis-Varón syndrome (FIG4), and DOORS syndrome (TBC1D24). Dr. Campeau's publication record demonstrates a strong trajectory in medical genetics research, with numerous high-impact publications spanning from fundamental genetic discovery to translational research. His work spans skeletal disorders, neurodevelopmental conditions, and epigenetic mechanisms. Recent publications indicate an expanding focus on chromatin modifiers, DNA methylation patterns, and spliceosome function in neurodevelopmental conditions, reflecting the evolution of his research interests toward more complex molecular mechanisms. Dr. Campeau has received several research grants in recent years (6 starting in 2014) from organizations including the Fonds de la recherche en santé du Québec, Canadian Institutes of Health Research, and Fondation Grand Défi Pierre Lavoie. While specific students are not mentioned in the available information, as a clinical professor, he mentors medical students, residents, and research trainees in the Department of Pediatrics. His research is conducted as part of the 'Musculoskeletal Diseases and Rehabilitation' axis at CHU Sainte-Justine Research Center, where he collaborates with international research teams to identify disease-causing genes and develop better management strategies for children with genetic disorders.

• Medical Genetics
• Bone Dysplasias
• Skeletal Dysplasias
• +12 more

Curtis Suttle is a Professor in the Department of Botany at the University of British Columbia's Faculty of Science. He also holds affiliations with Earth and Ocean Sciences, Microbiology and Immunology, and the Institute for Oceans and Fisheries. His research focuses on marine virology and the ecological roles of viruses in aquatic ecosystems, particularly their impact on phytoplankton and microbial communities. Dr. Suttle received his B.Sc. and Ph.D. from UBC, was a Coastal Marine Scholar at SUNY StonyBrook (1987-88), and served as Assistant/Associate Professor at the University of Texas at Austin (1988-96) before returning to UBC. His research program investigates the biology and ecology of viruses that infect microalgae and cyanobacteria. Key areas include discerning viral effects on primary productivity, isolating novel marine viruses, developing molecular identification methods, and studying viral distribution patterns. His work has revealed that viruses can occur in seawater at concentrations exceeding 10 5 ml -1 , with cyanophage concentrations reaching 10 6 infectious units ml -1 in coastal waters. Dr. Suttle's team has developed PCR primers specific for viral DNA polymerase genes, showing these viruses belong to a single family related to herpes viruses. Recent publications show a strong focus on marine viral ecology, with particular attention to oyster microbiomes, viral taxonomy, and the role of viruses in marine ecosystems. His research spans from coastal environments to the deepest ocean trenches, examining viral diversity across environmental gradients and investigating viral impacts on carbon cycling and marine food webs. Dr. Suttle leads an active research group with several post-doctoral associates, research scientists, and graduate students. His team conducts field work at multiple locations including the Naica Mine in Mexico, Pavilion Lake in British Columbia, Saanich Inlet, and the Strait of Georgia. Current projects include collaborations with the Hakai Institute, Line P Research Cruise, and CASES (Canadian Arctic Shelf Exchange Study). His laboratory has made significant contributions to understanding viral roles in marine ecosystems, particularly through expeditions to extreme environments like the Naica crystal caves and deep ocean trenches. Ongoing research explores viral impacts on microbial community structure, carbon cycling, and ecosystem function across diverse marine habitats.

• Marine Virology
• Aquatic Microbiology
• Phytoplankton Ecology
• +6 more

David Latulippe is a Professor in the Department of Chemical Engineering at McMaster University. He joined McMaster in 2012 after postdoctoral work at Cornell University and a PhD at Penn State University, focusing on membrane filtration for DNA purification. His industrial experience includes roles at ZENON Environmental (now GE Water) in hollow-fiber membrane design for water treatment. Research interests include Membrane science and technology Bioprocessing of therapeutic viruses Microscale systems for biological applications Environmental engineering solutions for water treatment Current projects involve collaborations with industry partners like Ceapro and Aevitas, and the development of a biomanufacturing automation lab with Sartorius. Recent publications highlight advancements in Nanofiltration and microfiltration for viral vectors Conductive membranes for electrochemical applications Microfluidic systems for DNA analysis Environmental monitoring of biocides and microplastics Scientific recognition includes the Young Membrane Scientist Award (2014). Teaching activities focus on Fluid Mechanics (CHEMENG 2O04) and Industrial Separation Processes (CHEMENG 4M03).

• Membrane Science
• Bioprocessing
• DNA Purification
• +4 more

James Lacefield is a Professor in both the Department of Electrical and Computer Engineering and the Department of Medical Biophysics at Western University. He serves as Director of the School of Biomedical Engineering and maintains his research laboratory in the Amit Chakma Engineering Building. His academic appointments span multiple disciplines, reflecting the interdisciplinary nature of his work in biomedical ultrasound imaging. Dr. Lacefield earned his Ph.D. and B.S.E. in Biomedical Engineering from Duke University. His educational background established the foundation for his current research program that bridges engineering principles with medical applications. His research focuses on the physical acoustics and signal processing aspects of ultrasound imaging, with particular emphasis on quantitative vascular imaging applications. Dr. Lacefield's laboratory develops novel methods for color Doppler, power Doppler, and contrast-enhanced ultrasound imaging, with primary applications in cancer research. Current projects include optimization of high-resolution ultrasound systems for tumor vascular characterization and development of methods to quantify spatial blood flow distribution in tumors. Analysis of his recent publications reveals a strong focus on quantitative ultrasound techniques for cancer applications, with particular attention to tumor perfusion assessment using contrast-enhanced ultrasound. His work demonstrates increasing sophistication in speckle analysis methods to improve the reliability of perfusion measurements in preclinical tumor models. Associate Editor, IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control Member, Council of Chairs of Bioengineering and Biomedical Engineering Member, College of Reviewers, Canadian Institutes of Health Research Dr. Lacefield maintains active collaborations with multiple research groups including the Imaging Research Laboratories at Robarts Research Institute. His professional activities include editorial work for major ultrasound journals and participation in national review panels for biomedical research funding.

• Biomedical Ultrasound Imaging
• Vascular Imaging
• Cancer Research Applications
• +5 more

Raymond T. Ng is a Professor of Computer Science at the University of British Columbia (UBC) and serves as Director of the Data Science Institute . In addition, he is the part-time Chief Informatics Officer at the PROOF Centre of Excellence for the Prevention of Organ Failures located at St Paul’s Hospital. Since 2016 he has held the prestigious Canada Research Chair in Data Science and Analytics. Education B.Sc. (Hons.) Computer Science, University of British Columbia, 1986 M.Math. Computer Science, University of Waterloo, 1988 Ph.D. Computer Science, University of Maryland, College Park, 1992 Research Interests Professor Ng’s research lies at the intersection of data mining , text mining , health informatics , sensor analytics , and databases . Over the past decade he has focused on two major domains: Genomics & Biomarker Discovery: Developing multi-omics biomarker panels for heart, lung and kidney transplant rejection and COPD exacerbations using transcriptomics, proteomics and metabolomics data. Natural Language Processing: Mining and summarizing conversational text such as emails, blogs and meeting transcripts to generate structured metadata and actionable insights. Scientific Awards Canada Research Chair in Data Science and Analytics (2016-2026) Best Paper Award, ACM SIGMOD 2004 Best Paper Award, ACM SIGKDD 2001 Selected among Best Papers of VLDB ’99 & ’98 Governor General’s Gold Medal, UBC (1986) Research Funding & Leadership Since joining UBC in 1992, Professor Ng has continuously secured major peer-reviewed funding from NSERC, CIHR, Genome Canada, CFI, MITACS and industry partners (Google, IBM, SAP). He leads or co-leads several large-scale initiatives: HEARTBiT multi-marker blood test for cardiac transplant rejection (CIHR 2018-2021) MERIDIAN ocean acoustic data infrastructure (CFI 2018-2021) Pan-Canadian Early Detection of Lung Cancer (Terry Fox 2018-2021) Business Intelligence Network (NSERC 2009-2014) Multiple Genome Canada programs on biomarker translation (2004-2018) Laboratories & Teams Professor Ng directs the Data Science Institute and works closely with the Natural Language Processing Research Group . At the PROOF Centre he heads a multidisciplinary team of statisticians, computer scientists and clinicians advancing computational biomarker pipelines from discovery to clinical implementation.

• Data Mining
• Text Mining
• Health Informatics
• +5 more

R. Glen Uhrig, PhD, is an Associate Professor of Plant Biology at the University of Alberta within the Department of Biological Sciences, Faculty of Science. His research focuses on plant functional genomics and proteomics, particularly examining diurnal regulation of cellular processes via quantitative proteomics in Arabidopsis thaliana and agriculturally relevant crops. The Uhrig Lab investigates post-translational modifications (PTMs) such as phosphorylation and acetylation to understand plant adaptation to environmental changes. Educationally, he holds a B.Sc.H. (2005) and M.Sc. (2008) from Queen’s University, followed by a Ph.D. from the University of Calgary (2013). His postdoctoral training at the Swiss Federal Institute of Technology (2017) furthered his expertise in plant systems biology. R. Glen Uhrig teaches courses including BIOL 343/543 (Macromolecular Characterization Techniques) and BOT 380 (Drug Plants), emphasizing hands-on proteomics and plant biotechnology. His awards include the ASTech Award (2022), NSERC Post-Doctoral Award (2015–2017), and the Marie Curie Plant Fellowship (2013–2015). His work bridges fundamental research with applications in agri-food production and crop resilience. Key research themes include: 1) Diurnal regulation of plant proteomes and PTMs, 2) Molecular mechanisms of plant immunity and stress responses, and 3) Leveraging proteomics to enhance crop productivity. The lab employs cutting-edge tools like quantitative mass spectrometry and multi-omics integration to address these questions.

• Plant Functional Genomics
• Quantitative Proteomics
• Post-Translational Modifications
• +4 more

Dr. Sara Beck is an Assistant Professor in the Department of Civil Engineering at the University of British Columbia. She leads the Beck Lab, focusing on water disinfection, UV LED technology, and environmental microbiology to address global water challenges. Her work bridges fundamental science and engineering applications, emphasizing sustainable solutions for public health and water quality. Education: Ph.D. in Environmental Engineering (2015, University of Colorado Boulder), M.S. in Environmental Engineering (Georgia Tech), B.S./B.A. in Aerospace Engineering/Studio Art (CU Boulder). Prior to academia, she worked as a NASA flight controller supporting Space Shuttle and ISS programs. Research Interests: UV disinfection mechanisms, water reuse, applied environmental microbiology, decentralized systems, and microplastic degradation. Key projects include UV LED applications for point-of-use disinfection, biofilm dynamics in filtration systems, and fecal contamination impacts on child health in low-resource settings. Awards: AEESP Outstanding Dissertation (2016), NSERC Discovery Accelerator (2021), Fulbright Scholar (2015), NASA Astronaut Finalist (2017). Lab members include PhD candidates Patrick Mirindi and Thusitha Rathnayake, and collaborators across global institutions. Grants: NSERC funding for UV LED research, WHO collaborations on surface disinfection protocols. Active research spans microbial communities in membranes, viral load quantification, and optimizing BWRO energy efficiency. Labs/Teams: Beck Lab @ UBC collaborates with interdisciplinary experts in engineering, microbiology, and policy to advance water treatment solutions. Current projects address microplastic prevalence in BC freshwater and surface disinfection standardization for healthcare settings.

• Environmental Engineering
• Water Disinfection
• UV LED Technology
• +4 more

Marc Roussel is a Professor in the Department of Chemistry and Biochemistry at the University of Lethbridge, affiliated with the Alberta RNA Research and Training Institute. His research focuses on mathematical modeling of biochemical systems, enzyme kinetics, and systems biology. He has authored multiple books, including Foundations of Chemical Kinetics and A Life Scientist's Guide to Physical Chemistry . His work bridges mathematics and biology, emphasizing dynamical systems, delay differential equations, and model reduction techniques. He has received the 2024 Distinguished Teaching Award from the University of Lethbridge. Key research areas include biochemical networks, gene expression dynamics, and metabolic modeling. Roussel collaborates with experimentalists to study complex biological phenomena such as circadian rhythms, somite formation, and enzyme mechanisms. His contributions span theoretical frameworks, computational methods, and interdisciplinary applications in systems biology.

• Biochemical Systems Analysis
• Mathematical Biology
• Chemical Kinetics
• +3 more

Sylvie Morin is a Full Professor in the Department of Chemistry at York University, affiliated with the Faculty of Science. She holds a Canada Research Chair in Surface and Interfacial Electrochemistry and has been recognized with awards such as the Premier’s Research Excellence Award (2004) and the Petro-Canada Young Innovator Award (2000). Her research focuses on electrochemical systems, nanomaterials, and energy storage solutions, particularly exploring electrodeposition techniques and nanostructured coatings for catalytic applications. Dr. Morin’s educational background includes a Ph.D. in Chemistry from the University of Ottawa (1996), an M.Sc. from the University of Guelph (1991), and a B.Sc. in Honours Chemistry from Université de Sherbrooke (1988). She has held academic positions at York University since 1999, including roles as Associate Dean and Interim Director of One WATER. Her research group collaborates on projects involving hydrogen production via water electrolysis and the development of sustainable electrocatalysts. Her research interests span scanning tunneling microscopy (STM), electrochemistry of transition metal oxides, and functionalized surfaces for biomedical analysis. Key projects include investigating nanostructured materials for energy conversion and corrosion-resistant coatings from deep eutectic solvents. Dr. Morin has supervised numerous graduate students and postdoctoral researchers, contributing to the training of high-quality human resources in materials science and electrochemistry. Scientific awards include: Canada Research Chair (2001–2010) York University’s Petro-Canada Young Innovator Award (2000) Alexander von Humboldt Research Fellowship (Germany, 1996–1999) Her research has been funded through grants supporting interdisciplinary work in electrochemistry, materials science, and sustainable energy technologies. Collaborations include studies on vaccine adjuvants and viral genome organization, demonstrating her cross-cutting scientific contributions. Dr. Morin’s lab focuses on advancing low-dimensional material systems, with ongoing projects exploring novel electrodeposition methods and the structural-properties relationships in nanomaterials.

• Electrochemistry
• Nanostructured Materials
• Surface Science
• +7 more

Hongquan Zhang serves as an Associate Professor in the Department of Laboratory Medicine & Pathology at the Faculty of Medicine & Dentistry, University of Alberta. His research program develops cutting-edge bioanalytical tools for ultrasensitive and point-of-care detection of biological targets, with a particular focus on infectious disease diagnostics. Education: Ph.D., University of Alberta (2009) M.Sc., Northwest University, Xi'an, China (1999) B.Sc., Northwest University, Xi'an, China (1997) Dr. Zhang's research explores binding-induced DNA assembly to create innovative diagnostic platforms. His laboratory specializes in developing fluorescent nanosensors for real-time detection in cellular environments, constructing target-triggered DNA nanomachines, and engineering novel affinity ligands through manipulation of functional nucleic acids. His work has made significant contributions to CRISPR-based diagnostics, particularly for SARS-CoV-2 detection, where his team has developed multiple point-of-care testing approaches that integrate nucleic acid amplification with CRISPR technology. Analysis of Dr. Zhang's recent publications reveals a strong research trajectory focused on integrating DNA nanotechnology with CRISPR systems to create streamlined diagnostic platforms. His work consistently addresses the challenge of moving complex molecular diagnostics from laboratory settings to point-of-care applications, with particular emphasis on sample preparation, signal amplification, and visual readout systems that eliminate the need for sophisticated equipment. The interdisciplinary nature of his research bridges chemistry, molecular biology, nanotechnology, and clinical medicine. Teaching: LABMP 551: Laboratory Research Methods LABMP 552: NSERC CREATE Course

• Biosensors
• Point-of-care diagnostics
• CRISPR technology
• +10 more

Daniel Baum is a Research Professor and Head of the Visual Data Analysis research group at the Zuse Institute Berlin (ZIB), which is affiliated with Freie Universität Berlin. His work spans across scientific visualization, computational biology, and image analysis, with a particular focus on developing methods for analyzing complex biological structures and neural circuits. He is actively involved in multiple interdisciplinary research projects including HFSP Chitons, Geometric Learning for Single-Cell RNA Velocity Modeling, and RobustCircuit. Dr. Baum's research interests center on visual and data-centric computing approaches to solve complex problems in biology and medicine. His work bridges the gap between computational methods and biological applications, with significant contributions to cryo-electron tomography analysis, neural circuit mapping, and geometric morphometrics. He develops innovative algorithms for 3D reconstruction, image segmentation, and visualization of biological structures, from molecular to organismal scales. His publication record demonstrates consistent contributions to visualization techniques applied to biological problems, with recent work focusing on neural circuit analysis in zebrafish and Drosophila, biomechanical studies of animal structures, and advanced methods for analyzing ancient artifacts. The research shows a clear trajectory toward increasingly sophisticated multimodal data integration and machine learning approaches. Dr. Baum leads a productive research group with several key collaborators who frequently appear as co-authors on his publications, indicating a strong mentoring relationship. His projects involve substantial funding from various sources supporting interdisciplinary collaborations across biology, computer science, and engineering. His laboratory at ZIB focuses on visual data analysis for complex biological systems, with particular strength in developing computational methods for neuroscience applications and biomaterial analysis. The group maintains strong collaborations with multiple institutions working on cutting-edge imaging technologies and biological model systems.

• Scientific Visualization
• Computational Biology
• Image Analysis
• +6 more

Dr. Stella Daskalopoulou is a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and a Professor in the Department of Medicine at McGill University's Faculty of Medicine and Health Sciences. She specializes in translational cardiovascular research with a focus on vascular health, atherosclerosis, and hypertension management. Senior Scientist, RI-MUHC Glen site Professor, Department of Medicine, McGill University Member, Cardiovascular Health Across the Lifespan Program Research Focus: Her work integrates biomedical technology with clinical investigation to identify early vascular impairment markers. Key areas include: Arterial stiffness and hemodynamic assessment Adiponectin signaling pathways in atherosclerosis Sex-specific cardiovascular risk stratification Biomarker discovery for plaque instability Pregnancy-related vascular complications Machine learning applications in plaque classification Scientific Engagement: Dr. Daskalopoulou contributes to hypertension guideline development (2024 ESC Guidelines) and explores environmental impacts on vascular health (household pollution studies). Her recent publications emphasize: Deep learning for plaque characterization Sex hormone receptor pathways in atherosclerosis Adipokine interactions with HDL metabolism Clinical decision tools for preeclampsia prediction Laboratory: Leads the Vascular Health Unit at RI-MUHC, combining histopathology, immunophenotyping, and advanced imaging for translational research.

• Vascular Biology
• Atherosclerosis
• Arterial Stiffness
• +2 more